Search clinical trials for: phenprocoumon

Total 30 results

St. Jude Children's Research Hospital
AbbVie

Recruiting

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Charite University, Berlin, Germany
Stiftung Institut fuer Herzinfarktforschung; Deutsches Zentrum für Herz-Kreislauf-Forschung... and other collaborators

Recruiting

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy (CLOSURE-AF)

Atrial Fibrillation

Germany
Stefan Engelter

Completed

Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD (TREAT-CAD)

Cervical Artery Dissection

Denmark, Germany, Switzerland
Atrial Fibrillation Network
Bristol-Myers Squibb; Pfizer

Completed

Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) (AXADIA)

Atrial Fibrillation | End-stage Kidney Disease

Germany
Bayer

Completed

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Venous Thromboembolism

Germany
Mylan Inc.
Winicker Norimed GmbH

Terminated

REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE)

Thromboembolism

Germany
Bayer
Janssen Research & Development, LLC

Completed

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon (ReLoaDeD)

Atrial Fibrillation

Germany
RWTH Aachen University
Bayer

Completed

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Atrial Fibrillation or Pulmonary Embolism | Need of Long Term Oral Anticoagulation Therapy (OAT) | Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location

Germany
LMU Klinikum
University Medicine Greifswald; Technical University of Munich; Helmholtz Zentrum... and other collaborators

Completed

APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF (APPROACH)

Coronary Artery Disease | Atrial Fibrillation | Acute Coronary Syndrome

Germany
LumiraDx UK Limited

Completed

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test (VKA GERMANY)

Anticoagulants and Bleeding Disorders

Germany
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation (ELIMINATE-AF)

Atrial Fibrillation

Spain, Belgium, Korea, Republic of, United Kingdom, Germany, Italy, Taiwan, Hungary, Czechia, Canada, Poland
G. d'Annunzio University

Completed

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Unsuspected Pulmonary Embolism

Spain, France, Netherlands, Italy, United States, Austria, Canada, Germany
Johannes Gutenberg University Mainz
Boehringer Ingelheim; Atrial Fibrillation Network

Terminated

Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF (RE-LATED_AF)

Atrial Fibrillation or Atrial Flutter | Thrombosis of Left Atrial Appendage

Germany
Boehringer Ingelheim

Completed

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Atrial Fibrillation

Germany
Bayer
Janssen Research & Development, LLC

Completed

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Atrial Fibrillation

Germany
Atrial Fibrillation Network
Bristol-Myers Squibb; Pfizer; Deutsches Zentrum für Herz-Kreislauf-Forschung...

Completed

Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy (AXAFA)

Atrial Fibrillation

United States, Austria, Belgium, Denmark, Germany, Italy, Netherlands, Spain, United Kingdom
Bayer
Janssen Research & Development, LLC

Completed

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Atrial Fibrillation

Germany
Hoffmann-La Roche

Completed

A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Malignant Melanoma, Neoplasms

Belgium, Spain, Germany, Netherlands, Finland
Deutsches Herzzentrum Muenchen

Unknown

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE)

Coronary Artery Disease | Atrial Fibrillation

Denmark, Germany
Daniel Zimpfer, MD

Terminated

Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

Thrombosis | Bleeding

Austria
University of Ulm
Boehringer Ingelheim

Unknown

Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon

Atrial Fibrillation | Left Atrial Thrombosis

Germany
RWTH Aachen University

Completed

Comparison of Phenprocoumon and Acetylsalicylic Acid (ASA)

Coronary Calcification | Valvular Calcification

Germany
Deutsches Herzzentrum Muenchen

Terminated

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-2)

Atherosclerosis | Atrial Fibrillation | Coronary Heart Disease | Acute Coronary Syndrome

Germany
University Medical Center Groningen

Terminated

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (Longheva)

Neoplasms | Venous Thromboembolism

Netherlands, United States, Canada, Italy, Germany
Medical University of Vienna

Completed

Antithrombotic Triple Therapy in Humans

Atrial Fibrillation | Acute Coronary Syndrome

Austria
Heart and Diabetes Center North-Rhine Westfalia
Klinikum Ludwigshafen; University of Kiel

Terminated

Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications (ESCAT III)

Mechanical Heart Valve Recipients

Germany
Deutsches Herzzentrum Muenchen

Completed

Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-1)

Atrial Fibrillation

Germany
Utrecht Institute for Pharmaceutical Sciences
Uppsala University; Erasmus Medical Center; Newcastle University; University of... and other collaborators

Completed

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon (EU-PACT)

Venous Thromboembolism (VTE) | Atrial Fibrillation (AF)

Germany, Austria, Netherlands
Cantonal Hospital of St. Gallen

Completed

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

Atrial Fibrillation | Pulmonary Embolism | Hip Replacement Postoperative | Knee Replacement Postoperative

Switzerland
University Hospital, Bonn
German Research Foundation; German Federal Ministry of Education and Research

Unknown

D-Dimer Guided Oral Anticoagulant Treatment (OAT) (DDOAT2006)

Deep Venous Thrombosis

Germany

Search clinical trials for: phenprocoumon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations